Peptidylarginine deiminase 3 modulates response to neratinib in HER2 positive breast cancer
Neratinib is a tyrosine kinase inhibitor that is used for the therapy of patients with HER2+ breast tumors. However, despite its clinical benefit, …
Category: Cell growth
NFIX suppresses breast cancer cell proliferation by delaying mitosis through downregulation of CDK1 expression
One of the fundamental biological characteristics of malignant tumors is their uncontrolled growth and multiplication, which is a major reason why …